Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin
scientific article published on 03 December 2012
Author/s
author: Graeme J. Hankey, Robert Califf, Kenneth W Mahaffey, Jonathan P. Piccini, Jonathan L. Halperin, Günter Breithardt, Yuliya Lokhnygina, Daniel E. Singer, Richard C Becker, Manesh Patel, Keith Fox, Christopher C Nessel, Werner Hacke, ROCKET AF Steering Committee and Investigators, Susanna R Stevens, Yuchiao Chang, Alan S Go
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.